Trials / Conditions / Clostridium Enterocolitis

Clostridium Enterocolitis

9 registered clinical trials studyying Clostridium Enterocolitis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications NCT07240649	Jay C. Buckey Jr.	Phase 4
Completed	Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis NCT00304889	Michael E. DeBakey VA Medical Center	—
Completed	Response of Clostridium Difficile Infection to Metronidazole Therapy NCT00304369	Michael E. DeBakey VA Medical Center	—
Completed	A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associ NCT00196794	Genzyme, a Sanofi Company	Phase 3
Completed	A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Assoc NCT00106509	Genzyme, a Sanofi Company	Phase 3
Completed	Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody NCT00304408	Michael E. DeBakey VA Medical Center	—
Completed	Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment NCT00182429	McMaster University	Phase 3
Completed	Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection NCT00304356	Daniel M. Musher MD	Phase 3
Completed	A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea NCT00034294	Genzyme, a Sanofi Company	Phase 2